NCT03905538 2024-03-01
Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Withdrawn
Clinical Trials
5 trialsNCT04316169 2022-12-23
Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
Medical College of Wisconsin
Phase 1 Withdrawn
NCT03166176 2019-05-20
TSC1/2_SC
Samsung Medical Center
Phase 2 Withdrawn
NCT03166904 2019-05-20
RICTOR_SC
Samsung Medical Center
Phase 2 Withdrawn
NCT02656849 2016-07-01
BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
Dana-Farber Cancer Institute
Phase 2 Withdrawn